Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

3(42.9%)

Phase 1

1(14.3%)

7Total

Phase 2(3)

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01583920Not ApplicableActive Not Recruiting

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Role: collaborator

NCT04197141Phase 2Active Not Recruiting

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

Role: collaborator

NCT01578902Not ApplicableCompleted

Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer

Role: collaborator

NCT01146340Phase 1Completed

Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer

Role: collaborator

NCT01973673Not ApplicableCompleted

Healthy Bones Study

Role: collaborator

NCT00188799Phase 2Completed

Xray Volume Imaging (Cone Beam CT) - Prostate Cancer

Role: collaborator

NCT01355185Unknown

Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences

Role: collaborator

NCT00160953Phase 2Completed

Endorectal Coil Magnetic Resonance Images (ERC-MRI)

Role: collaborator

All 8 trials loaded